Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-669899f699-7tmb6 Total loading time: 0 Render date: 2025-04-28T19:39:14.026Z Has data issue: false hasContentIssue false

20 - Surgical Resection of Hepatic Metastases

from PART III - ORGAN-SPECIFIC CANCERS

Published online by Cambridge University Press:  18 May 2010

By
Michael A. Choti
Edited by
Jean-François H. Geschwind  and
Michael C. Soulen
Michael A. Choti
Affiliation:
Professor of Radiology and Surgery Division of Interventional Radiology, University of Pennsylvania Philadelphia, PA
Jean-François H. Geschwind
Affiliation:
The Johns Hopkins University School of Medicine
Michael C. Soulen
Affiliation:
University of Pennsylvania School of Medicine
Get access

Summary

PRIMARY LIVER CANCER

Hepatocellular carcinoma (HCC) is the most common type of common primary liver cancer and is associated with more than one million cases diagnosed worldwide each year. Other histologic types, including intrahepatic cholangiocarcinoma, while less common than HCC, are also experiencing a rise in incidence in the United States in recent years (1, 2). Complex management options confront those treating patients with primary liver cancer, making a multi-disciplinary team comprising hepatologists, diagnostic and interventional radiologists, medical oncologists, radiation oncologists, transplant surgeons and surgical oncologists important for optimal care. In patients without cirrhosis, surgical resection of primary liver cancer with partial hepatectomy is the treatment of choice; however, no more than 30% of patients have resectable disease, and when cirrhosis is present, fewer than 10% are resectable (3, 4). The presence of extrahepatic disease, lack of sufficient hepatic function reserve, multi-focal disease within the liver and suboptimal tumor location are all common reasons for unresectability in these patients.

HEPATIC METASTASES

Metastatic disease is the most common malignancy of the liver in the United States. The liver is the most common site for developing metastases, accounting for more than one-half of cases of advanced cancer. Although primary tumors originating from gastrointestinal sites are more likely than others to develop hepatic metastases, many tumors arising in other locations, including those of the breast and lung, also commonly develop hepatic metastases.

Type
Chapter
Information
Interventional Oncology
Principles and Practice
 , pp. 243 - 248
Publisher: Cambridge University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

El-Serag, H B and Mason, A C. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med, 1999 Mar 11; 340(10): 745–750.CrossRefGoogle Scholar
DeOliveira, M L, Cunningham, S C, Cameron, J L, et al. Cholangiocarcinoma: Thirty-one-year experience with 564 patients at a single institution. Ann Surg, 2007 May; 245(5): 755–762.CrossRefGoogle Scholar
Mor, E, Kaspa, R T, Sheiner, P, et al. Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation. Ann Intern Med, 1998 Oct 15; 129(8): 643–653.CrossRefGoogle Scholar
Farmer, D G, Rosove, M H, Shaked, A, et al. Current treatment modalities for hepatocellular carcinoma. Ann Surg, 1994 Mar; 219(3): 236–247.CrossRefGoogle Scholar
Jemal, A, Murray, T, Ward, E, et al. Cancer Statistics, 2005. CA Cancer J Clin, 2005; 55: 10–30.CrossRefGoogle ScholarPubMed
Steele, G Jr and Ravikumar, T S. Resection of hepatic metastases from colorectal cancer: Biologic perspective. Ann Surg, 1989; 210: 127–138.CrossRefGoogle ScholarPubMed
Capussotti, L and Polastri, R. Operative risks of major hepatic resections. Hepatogastroenterology, 1998; 45: 184–190.Google ScholarPubMed
Sitzmann, J V and Greene, P S. Perioperative predictors of morbidity following hepatic resection for neoplasm: A multivariate analysis of a single surgeon's experience with 105 patients. Ann Surg, 1994; 219: 13–17.CrossRefGoogle Scholar
Belghiti, J, Hiramatsu, K, Benoist, S, et al. Seven hundred forty-seven hepatectomies in the 1990s: An update to evaluate the actual risk of liver resection. J Am Coll Surg, 2000; 191: 38–46.CrossRefGoogle ScholarPubMed
Farges, O, Malassagne, B, Flejou, J F, et al. Risk of major liver resection in patients with underlying chronic liver disease: A reappraisal. Ann Surg, 1999; 229(2): 210–215.CrossRefGoogle ScholarPubMed
Kokudo, N, Imamura, H, Sugawara, Y, et al. Surgery for multiple hepatic colorectal metastases. J Hepatobiliary Pancreat Surg, 2004;11: 84–91.CrossRefGoogle ScholarPubMed
Weber, S M, Jarnagin, W R, DeMatteo, R P, et al. Survival after resection of multiple hepatic colorectal metastases. Ann Surg Oncol, 2000; 7: 643–650.CrossRefGoogle ScholarPubMed
Iwatsuki, S, Dvorchik, I, Madariaga, J R, et al. Hepatic resection for metastatic colorectal adenocarcinoma: A proposal of a prognostic scoring system. J Am Coll Surg, 1999; 189: 291–299.CrossRefGoogle ScholarPubMed
Abdalla, E K, Denys, A, Chevalier, P, et al. Total and segmental liver volume variations: Implications for liver surgery. Surgery, 2004 Apr; 135(4): 404–410.CrossRefGoogle Scholar
Yigitler, C, Farges, O, Kianmanesh, R, et al. The small remnant liver after major liver resection: How common and how relevant?Liver Transpl, 2003 Sep; 9(9): S18–25.CrossRefGoogle Scholar
Abdalla, E K, Hicks, M E, and Vauthey, J N. Portal vein embolization: Rationale, technique and future prospects. Br J Surg, 2001; 88: 165–175.CrossRefGoogle ScholarPubMed
Khatri, V P, Petrelli, N J, and Belghiti, J. Extending the frontiers of surgical therapy for hepatic colorectal metastases: Is there a limit?J Clin Oncol, 2005 Nov 20; 23(33): 8490–8499.CrossRefGoogle Scholar
Farges, O, Malassagne, B, Flejou, J F, et al. Risk of major liver resection in patients with underlying chronic liver disease: A reappraisal. Ann Surg, 1999; 229(2): 210–215.CrossRefGoogle ScholarPubMed
Lee, C S, Sheu, J C, Wang, M, et al. Long-term outcome after surgery for asymptomatic small hepatocellular carcinoma. Br J Surg, 1996; 83(3): 330–333.CrossRefGoogle ScholarPubMed
Vauthey, J N, Klimstra, D, Franceschi, D, et al. Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg, 1995; 169.Google ScholarPubMed
Poon, R T, Fan, S T, Lo, C M, et al. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: Implications for a strategy of salvage transplantation. Ann Surg, 2002 Mar; 235(3): 373–382.CrossRefGoogle Scholar
Choti, M A, Bowman, H M, Pitt, H A, et al. Should hepatic resections be performed at high-volume referral centers?J Gastrointest Surg, 1998; 2:11–20.CrossRefGoogle ScholarPubMed
Poon, R T, Fan, S T, Lo, C M, et al. Difference in tumor invasiveness in cirrhotic patients with hepatocellular carcinoma fulfilling the Milan criteria treated by resection and transplantation: Impact on long-term survival. Ann Surg, 2007 Jan; 245(1): 51–58.CrossRefGoogle Scholar
Scheele, J, Stang, R, Altendorf-Hofmann, A, et al. Resection of colorectal liver metastases. World J Surg, 1995; 19: 59–71.CrossRefGoogle ScholarPubMed
Fong, Y, Fortner, J, Sun, R L, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases. Ann Surg, 1999; 230: 309–318; discussion 318–321.CrossRefGoogle ScholarPubMed
Choti, M A, Sitzmann, J V, Tiburi, M F, et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg, 2002; 235: 759–766.CrossRefGoogle ScholarPubMed
Fong, Y, Cohen, A M, Fortner, J G, et al. Liver resection for colorectal metastases. J Clin Oncol, 1997; 15: 938–946.CrossRefGoogle ScholarPubMed
Pawlik, T M, Scoggins, C R, Zorzi, D, et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg, 2005; 241: 715–722, discussion 722–714.CrossRefGoogle ScholarPubMed
Abdalla, E K, Vauthey, J N, Ellis, L M, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg, 2004; 239: 818–825.CrossRefGoogle ScholarPubMed
Fernandez, F G, Drebin, J A, Linehan, D C, et al. Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg, 2004; 240: 438–447.CrossRefGoogle Scholar
Nordlinger, B, Guiguet, M, Vaillant, J C, et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie. Cancer, 1996; 77: 1254–1262.3.0.CO;2-I>CrossRefGoogle Scholar
Pawlik, T M, Abdalla, E K, Ellis, L M, et al. Debunking dogma: Surgery for four or more colorectal liver metastases is justified. J Gastrointest Surg, 2006 Feb; 10(2): 240–248.CrossRefGoogle Scholar
Chen, H, Hardacre, J M, Uzar, A, et al. Isolated liver metastases from neuroendocrine tumors: Does resection prolong survival?J Am Coll Surg, 1998 Jul; 187(1): 88–92.CrossRefGoogle Scholar
Harrison, L E, Brennan, M F, Newman, E, et al. Hepatic resection for noncolorectal, nonneuroendocrine metastases: A fifteen-year experience with ninety-six patients. Surgery, 1997; 121: 625–632.CrossRefGoogle ScholarPubMed
Benevento, A, Boni, L, Frediani, L, et al. Result of liver resection as treatment for metastases from noncolorectal cancer. J Surg Oncol, 2000 May; 74(1): 24–29.3.0.CO;2-V>CrossRefGoogle Scholar
Chen, H, Pruitt, A, Nichol, T L, et al. Complete hepatic resection of metastases from leiomyosarcoma prolongs survival. J Gastrointest Surg, 1998; 2(2): 151–155.CrossRefGoogle ScholarPubMed
Adam, R, Chiche, L, Aloia, T, et al. Hepatic resection for noncolorectal nonendocrine liver metastases: Analysis of 1,452 patients and development of a prognostic model. Ann Surg, 2006 Oct; 244(4): 524–535.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×